PARP1 and neoplasm: Perhaps the best known example of such phenomenon involves mutations and/or low expression of BRCA1/2, whereby HR deficiency sensitizes tumor cells to inhibit PARP1, a critical mediator of the corresponding DNA single-strand break repair pathway [17,61,62,63].